HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Novel process of intrathymic tumor-immune tolerance through CCR2-mediated recruitment of Sirpα+ dendritic cells: a murine model.

Abstract
Immune surveillance system can detect more efficiently secretory tumor-specific antigens, which are superior as a target for cancer immunotherapy. On the contrary, immune tolerance can be induced in the thymus when a tumor antigen is massively secreted into circulation. Thus, the secretion of tumor-specific antigen may have contradictory roles in tumor immunity in a context-dependent manner. However, it remains elusive on the precise cellular mechanism of intrathymic immune tolerance against tumor antigens. We previously demonstrated that a minor thymic conventional dendritic cell (cDC) subset, CD8α(-)Sirpα(+) cDCs, but not the major subset, CD8α(+)Sirpα(-) cDCs can selectively capture blood-borne antigens and crucially contribute to the self-tolerance. In the present study, we further demonstrated that Sirpα(+) cDCs can capture a blood-borne antigen leaking inside the interlobular vascular-rich regions (IVRs). Blood-borne antigen selectively captured by Sirpα(+) cDCs can induce antigen-specific Treg generation or negative selection, depending on the immunogenicity of the presented antigen. Furthermore, CCR2 expression by thymic Sirpα(+) cDCs and abundant expression of its ligands, particularly, CCL2 by tumor-bearing mice prompted us to examine the function of thymic Sirpα(+) cDCs in tumor-bearing mice. Interestingly, tumor-bearing mice deposited CCL2 inside IVRs in the thymus. Moreover, tumor formation induced the accumulation of Sirpα(+) cDCs in IVRs under the control of CCR2-CCL2 axis and enhanced their capacity to take up antigens, resulting in the shift from Treg differentiation to negative selection. Finally, intrathymic negative selection similarly ensued in CCR2-competent mice once the tumor-specific antigen was secreted into bloodstream. Thus, we demonstrated that thymic Sirpα(+) cDCs crucially contribute to this novel process of intrathymic tumor immune tolerance.
AuthorsTomohisa Baba, Mohamed El Sherif Badr, Utano Tomaru, Akihiro Ishizu, Naofumi Mukaida
JournalPloS one (PLoS One) Vol. 7 Issue 7 Pg. e41154 ( 2012) ISSN: 1932-6203 [Electronic] United States
PMID22815949 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antigens, Differentiation
  • CCR2 protein, human
  • CD11 Antigens
  • Ccr2 protein, mouse
  • Interleukin-2
  • Ligands
  • Ptpns1 protein, mouse
  • Receptors, CCR2
  • Receptors, Immunologic
  • SIRPA protein, human
  • Green Fluorescent Proteins
Topics
  • Animals
  • Antigens, Differentiation (biosynthesis)
  • CD11 Antigens (biosynthesis)
  • CD8-Positive T-Lymphocytes (cytology)
  • Dendritic Cells (metabolism)
  • Gene Deletion
  • Green Fluorescent Proteins (metabolism)
  • Humans
  • Immune Tolerance
  • Interleukin-2 (metabolism)
  • Ligands
  • Male
  • Mice
  • Mice, Inbred BALB C
  • Mice, Inbred C57BL
  • Mice, Transgenic
  • Microscopy, Fluorescence (methods)
  • Protein Binding
  • Receptors, CCR2 (metabolism)
  • Receptors, Immunologic (biosynthesis)
  • Thymocytes (cytology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: